Worldwide variations in EGFR somatic mutations: a challenge for personalized medicine

od Lamy, Pierre-Jean, Jacot, William
Izdano 2012

TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?

od Lamy, Pierre-Jean, Jacot, William
Izdano 2012

Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Breast Cancer Patients: A Systematic Review

od Corbeau, Iléana, Jacot, William, Guiu, Séverine
izdano v Cancers (Basel) (2020)

Severe Peritonitis Induced by Methotrexate During Treatment of Persistent Gestational Trophoblastic Disease

od Zimmermann, Stefan, Zaman, Khalil, Wolfer, Anita, Jacot, William
Izdano 2012

High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker

od Papadakos, Konstantinos S., Darlix, Amélie, Jacot, William, Blom, Anna M.
izdano v Front Oncol (2019)

CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers

od Boissière-Michot, Florence, Jacot, William, Massol, Océane, Mollevi, Caroline, Lazennec, Gwendal
izdano v Cancers (Basel) (2021)

Anti-HER2 vaccines: new prospects for breast cancer therapy

od Ladjemi, Maha Zohra, Jacot, William, Chardès, Thierry, Pèlegrin, André, Navarro-Teulon, Isabelle
Izdano 2010

Prognostic Value of CXCR2 in Breast Cancer

od Boissière-Michot, Florence, Jacot, William, Fraisse, Julien, Gourgou, Sophie, Timaxian, Colin, Lazennec, Gwendal
izdano v Cancers (Basel) (2020)

Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases

od Braccini, Antoine-Laurent, Azria, David, Thezenas, Simon, Romieu, Gilles, Ferrero, Jean-Marc, Jacot, William
Izdano 2013

Inflammatory Blood Markers as Prognostic and Predictive Factors in Early Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

od Corbeau, Ileana, Thezenas, Simon, Maran-Gonzalez, Aurelie, Colombo, Pierre-Emmanuel, Jacot, William, Guiu, Severine
izdano v Cancers (Basel) (2020)

Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study

od Jacot, William, Gerlotto-Borne, Marie-Cécile, Thezenas, Simon, Pouderoux, Stéphane, Poujol, Sylvain, About, Mahdi, Romieu, Gilles
Izdano 2010

Comparison of Supervised Classification Methods for Protein Profiling in Cancer Diagnosis

od Dossat, Nadège, Mangé, Alain, Solassol, Jérôme, Jacot, William, Lhermitte, Ludovic, Maudelonde, Thierry, Daurès, Jean-Pierre, Molinari, Nicolas
Izdano 2007

Lack of EGFR-activating mutations in European patients with triple-negative breast cancer could emphasise geographic and ethnic variations in breast cancer mutation profiles

od Jacot, William, Lopez-Crapez, Evelyne, Thezenas, Simon, Senal, Romain, Fina, Frédéric, Bibeau, Frédéric, Romieu, Gilles, Lamy, Pierre-Jean
Izdano 2011

Age and stage at diagnosis: a hospital series of 11 women with intellectual disability and breast carcinoma

od Satgé, Daniel, Sauleau, Eric-André, Jacot, William, Raffi, Fernand, Azéma, Bernard, Bouyat, Jean-Claude, El Hage Assaf, Nicolas
Izdano 2014

CBM-07 SERUM NSE, MMP-9 AND HER2 ARE PREDICTIVE OF BRAIN METASTASES IN METASTATIC BREAST CANCER PATIENTS

od Darlix, Amélie, Lamy, Pierre-Jean, Crapez, Evelyne, Braccini, Antoine Laurent, Firmin, Nelly, Romieu, Gilles, Thezenas, Simon, Jacot, William
izdano v Neuro Oncol (2015)

Quantification and clinical relevance of gene amplification at chromosome 17q12-q21 in human epidermal growth factor receptor 2-amplified breast cancers

od Lamy, Pierre-Jean, Fina, Frédéric, Bascoul-Mollevi, Caroline, Laberenne, Anne-Claire, Martin, Pierre-Marie, Ouafik, L'Houcine, Jacot, William
Izdano 2011

Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients

od Darlix, Amélie, Lamy, Pierre-Jean, Lopez-Crapez, Evelyne, Braccini, Antoine Laurent, Firmin, Nelly, Romieu, Gilles, Thezenas, Simon, Jacot, William
izdano v BMC Cancer (2016)

Full-length cytokeratin-19 is released by human tumor cells: a potential role in metastatic progression of breast cancer

od Alix-Panabières, Catherine, Vendrell, Jean-Pierre, Slijper, Monique, Pellé, Olivier, Barbotte, Eric, Mercier, Grégoire, Jacot, William, Fabbro, Michel, Pantel, Klaus
Izdano 2009

Decision of Adjuvant Systemic Treatment in HR+ HER2- Early Invasive Breast Cancer: Which Biomarkers Could Help?

od Alexandre, Marie, Maran-Gonzalez, Aurélie, Viala, Marie, Firmin, Nelly, D’Hondt, Véronique, Gutowski, Marian, Bourgier, Céline, Jacot, William, Guiu, Séverine
izdano v Cancer Manag Res (2019)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer

od Boissière-Michot, Florence, Chabab, Ghita, Mollevi, Caroline, Guiu, Séverine, Lopez-Crapez, Evelyne, Ramos, Jeanne, Bonnefoy, Nathalie, Lafont, Virginie, Jacot, William
izdano v Cancers (Basel) (2021)